TLR9 and oral lichen planus: Finally, the therapeutic strategy where PAMAM-G3 removes cfDNA to inhibit inflammation needs to be validated via an OLP mice model, and the roles of other DNA sensors, such as TLR9 and AIM2, should also be investigated in OLP.